Skin Analytics key facts
as of Oct 2026- Developer of a skin cancer screening technology designed to help in the early detection of cancer.
- Skin Analytics is valued at approximately $68.5M as of Oct 2026 (last reported valuation).
- It has raised $42.9M; the latest was Accelerator/Incubator in Sep 2025.
- Notable investors include Innovate UK, Tech Nation Group, UK Research and Innovation, Hoxton Ventures, Bethnal Green Ventures — 31 tracked in total.
- Status: Privately Held (backing).
Skin Analytics's last reported valuation, Apr 2025. Nothing priced has surfaced since.
- ·The complete investor list: 31 names
- ·Watch Skin Analytics: the Monday email on marks, rounds and moves
Skin Analytics funding rounds
No funding rounds for Skin Analytics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Skin Analytics
31+Skin Analytics valuation
Skin Analytics's last reported valuation was $68.5 million in Apr 2025. No priced round, secondary trade or fund mark has surfaced since.
Skin Analytics investors
31 investors are on record for Skin Analytics, including Innovate UK, Tech Nation Group, UK Research and Innovation and Hoxton Ventures.
About Skin Analytics
Developer of a skin cancer screening technology designed to help in the early detection of cancer. The company uses artificial intelligence and algorithms to monitor changes in moles and skin lesions and identify skin cancers and precancerous lesions, enabling healthcare providers, particularly within the NHS, to improve patient management efficiency and reduce wait times for skin cancer diagnosis.
- Sector
- Healthcare
- HQ
- Cambridge, United Kingdom
- Founded
- 2012
- Employees
- 94
- Website
- skin-analytics.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.